Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)

6 Feb 2014

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Lung Cancer Treatments and Mutations
Share to Melanoma and MAPK Pathways

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 24508104
DOI: 10.1016/s1470-2045(13)70611-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)PMID 24508104Read ↗

Genomics to select treatment for patients with metastatic breast cancerSemantic proximity Read ↗

Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trial.Semantic proximity Read ↗

Clinical implications of prospective genomic profiling of metastatic breast cancer patients.Semantic proximity Read ↗

Targeted NGS, array-CGH, and patient-derived tumor xenografts for precision medicine in advanced breast cancer: a single-center prospective study.Semantic proximity Read ↗

Evaluation of targeted therapies in advanced breast cancer: the need for large-scale molecular screening and transformative clinical trial designsSemantic proximity Read ↗

Whole Exome Analysis to Select Targeted Therapies for Patients with Metastatic Breast or Advanced Gynecological Cancer -A Feasibility Study-Semantic proximity Read ↗

Array CGH and PIK3CA/AKT1 mutations to drive patients to specific targeted agents: a clinical experience in 108 patients with metastatic breast cancer.Semantic proximity Read ↗

High-depth sequencing of paired primary and metastatic tumours: Implications for personalised medicine.Semantic proximity Read ↗

Complementary information provided by simultaneous sequencing of CTC, cfDNA and metastatic tissue in endocrine-resistant metastatic breast cancerSemantic proximity Read ↗

The MINDACT trial: the first prospective clinical validation of a genomic tool.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.